Illness	Number of cases
Cerebral infarction (I63.3)	142
Cerebral infarction (I63.4)	121
Epilepsy (G40.2)	71
Disorders of vestibular function (H81.1)	69
Disorders of vestibular function (H81.2)	66
Carotid artery syndrome hemispheric (G45.12)	64
Migraine (G43.1)	52
Carotid artery syndrome hemispheric (G45.13)	39
Migraine (G43.2)	38
Epilepsy (G40.3)	30

Top 10 treatments

Treatment	Number
Measurement of the brain waves - EEG (1-207.0)	689
Examination of the cerebrospinal fluid spaces (1-204.2)	279
Examination of nerve conduction - ENG (1-206)	274
Measurement of brain waves triggered by targeted stimuli (evoked potentials) (1-208.2)	217
Other examination of the function of the nervous system (1-20a.33)	183
(8-981.20)	155
(9-984.7)	128
(9-984.8)	114
Measurement of brain waves triggered by targeted stimuli (evoked potentials) (1-208.4)	108
Treatment by injecting a medicine into an organ or tissue, or removal of excess fluid (effusion) e.g. from the joints (8-020.8)	97

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2800

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	0

External quality assurance according to the DMP

Brustkrebs

Das InnKlinikum Altötting hat am DMP Brustkrebs bereits im Jahr 2006 teilgenommen. Sie erfüllt die geforderte Strukturqualität und ist berechtigt zum Führen der Zusatzbezeichnung "Brustzentrum /DMP). Ein Zertifikat liegt seit dem Jahr 2007 vor.

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ06	Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
95	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
27	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
27	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Lectureships / teaching posts at colleges and universities
Lectureships / teaching posts at universities of applied sciences
Participation in multi-centre Phase I/II studies
Participation in multi-centre phase III/IV studies	HD 18 (Non Hodgkin Lymphom Studie, AGO-OVAR 2.21 und SUCCESS C-Studie, TKK III (ColQ) offen prospektiv multizentrisch, Optim OL -Studie, Deutsche Leberhilfe, Phase III zu den Indikationen Großgefäßvaskulitis, Phase IV/Register des DRheu.fo.Z
Doctoral supervision	Herrn PD Dr. M. Feuchtgenberger, Klinik für Viszeral- und Allgemeinchirurgie Prof. Dr. C. Jurowich, Klinik für Urologie, Klinik für Neurologie, Prof. Dr. med H. Rambold

Training

No.	Training in other healing professions	Comment
HB01	Nurse and health care worker (m/f)
HB02	Health and paediatric nurse (m/f)
HB13	Medical technical assistant for functional diagnostics (MTAF) (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)
HB19	Nursing professionals